Explore more publications!

West Virginia Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on West Virginia Healthcare Press.

Press releases published on October 28, 2025

Avance Clinical Unveils Dedicated CNS Center of Excellence for Expert Clinical Trial Services in Neuroscience
Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations
Little Leaves Behavioral Services Continues Strategic Expansion With Two New ABA Therapy Centers in Virginia
Quoin Pharmaceuticals Announces Recruitment of Three Additional Patients in Investigator Pediatric Netherton Syndrome Study and Provides Positive 9 month ‘Whole Body’ Data Update from Ongoing Study
Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026
Bring the Gym Home: THERUN Unveils Foldable Auto-Incline Treadmill for Home Fitness
More than 10,000 people receive verified World IDs at  MEDIROM locations
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Working to Transform Underperforming Compounds into Next-Gen Cancer Therapies
Clearmind Medicine CEO Dr. Adi Zuloff-Shani to Speak at Women in Psychedelic Leadership Webinar
Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer
BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025
Pacira BioSciences Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-to-Severe Osteoarthritis of the Knee
Soleno Therapeutics to Participate in Upcoming November Conferences
Cidara Therapeutics to Participate in November Investor Conferences
Targeted Genomics Launches CeliacDx Consumer-Initiated Testing Service
AssistRx Named a Winner of the Orlando Sentinel Media Group’s Central Florida Top Workplaces 2025 Award
CervoMed Strengthens Board with Appointment of Life Sciences Business Strategy Leader David Quigley
Madrigal to Present New Data from the Company’s MASH Program at AASLD’s The Liver Meeting 2025
Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025
Josh Ruben Joins PetVivo Holdings, Inc. Board of Directors

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions